BioSpace News Archive

Pharm Country

Roivant Announces Protein Degradation Platform Using VantAI Against Difficult Drug Targets

Roivant Sciences announced its targeted protein degradation platform, with its first pipeline candidate expected to enter the clinic in 2021.

December 7, 2020
·
3 min read
·
Mark Terry
Deals

COVID-19 Antibody Discovery Company Preps for Massive $391 Million IPO

With support from Peter Thiel, Eli Lilly partner AbCellera looks to join the NASDAQ with the biggest Canadian biotech debut on record.

December 7, 2020
·
2 min read
·
Kate Goodwin
Drug Development

NeuroRx and Relief Therapeutics Meet 165 Patient Enrollment Target in Phase 2b/3 Trial of RLF-100™ for Critical COVID-19 with Respiratory Failure

NeuroRx, Inc. and Relief Therapeutics Holdings AG announced that they have met the 165 patient enrollment target agreed with the U.S. Food and Drug Administration in the ongoing phase 2b/3 trial of RLF-100™ for treating Respiratory Failure in patients with Critical COVID-19.

December 7, 2020
·
7 min read
Fecal Immunochemical Diagnostic Tests Market: Increased cases of colorectal cancer across the globe is expected to drive the market

Increased cases of colorectal cancer across the globe are predicted to drive sales opportunities in the global fecal immunochemical diagnostic tests market during the assessment period of 2020 to 2030.

December 7, 2020
·
4 min read
Viral RNA Extraction Kit Market: A Surge in Cases of Various Diseases is Expected to Accentuate Demand in the Market

Viral RNA extraction kit refers to an important indicator for the purpose of separation of trace amounts of viral RNA from given samples together with body fluids, plasma, serum, and blood.

December 7, 2020
·
4 min read
Luciferase Assays Market: Considerable Technological Progress and Growing Importance to Accentuate Market Demand

The luciferase assay is utilized in the determination of whether a protein can repress or activate the expression of a gene that has been targeted.

December 7, 2020
·
4 min read
Lateral Flow Assay Market | Current Scenario with Future Scope Analysis Report

The high prevalence of infectious diseases globally, rapidly aging population, growing demand for point-of-care testing, and home-based lateral flow assay devices are the major factors driving the growth of this market.

December 7, 2020
·
3 min read
Surgical Lasers Market Growth Drivers and Restrains Analysis Report to 2025

Surgical laser products are used in laser surgeries to destroy or cut abnormal or diseased tissues, destroy or shrink lesions and tumors, seal lymph vessels, remove moles and tattoos, and close off blood vessels and nerve endings among various other uses.

December 7, 2020
·
4 min read
Business

Rexgenero Appoints Sadia L’Baouch as Chief Manufacturing Officer

Rexgenero, a regenerative medicine company developing advanced cell therapies to treat chronic limb-threatening ischemia, announces the appointment of Sadia L’Baouch as Chief Manufacturing Officer, effective 4 January 2021.

December 7, 2020
·
4 min read
Oncopeptides will host a webcast on Wednesday, December 9th at 14:00 (CET) to provide an update regarding data presented at the ASH annual meeting

Oncopeptides AB announces that the company will host a webcast on Wednesday, December 9th, 2020, at 14:00 to provide an update regarding the data presented December 4-8 at the American Society Hematology Annual Meeting 2020.

December 7, 2020
·
3 min read